0000950170-24-046095.txt : 20240419 0000950170-24-046095.hdr.sgml : 20240419 20240419170815 ACCESSION NUMBER: 0000950170-24-046095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240417 FILED AS OF DATE: 20240419 DATE AS OF CHANGE: 20240419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Esser Eric Eugene CENTRAL INDEX KEY: 0001933819 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40497 FILM NUMBER: 24858778 MAIL ADDRESS: STREET 1: C/O CODEX DNA, INC. STREET 2: 9535 WAPLES STREET, SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Telesis Bio Inc. CENTRAL INDEX KEY: 0001850079 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 451216839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10431 WATERIDGE CIRCLE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-228-4115 MAIL ADDRESS: STREET 1: 10431 WATERIDGE CIRCLE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Codex DNA, Inc. DATE OF NAME CHANGE: 20210309 4 1 ownership.xml 4 X0508 4 2024-04-17 0001850079 Telesis Bio Inc. TBIO 0001933819 Esser Eric Eugene C/O TELESIS BIO INC. 10431 WATERIDGE CIRCLE, SUITE 150 SAN DIEGO CA 92121 true true false false President & CEO false Common Stock 2024-04-17 4 A false 100000 0 A 129260 D Stock Option (right to buy) 0.38 2024-04-17 4 A false 200000 0 A 2034-04-17 Common Stock 200000 200000 D The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 50% of the RSUs shall vest on April 17, 2025, and the remaining 50% of the RSUs shall vest on April 17, 2026. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, 25% of the shares subject to the option shall vest on April 17, 2025, and 1/36th of the remaining shares subject to the option shall vest each month thereafter. /s/ Rob Cutler, as Attorney-in-Fact 2024-04-19